| Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy JI van Waning, K Caliskan, YM Hoedemaekers, ... Journal of the American College of Cardiology 71 (7), 711-722, 2018 | 287 | 2018 |
| Cardiac complications in patients hospitalised with COVID-19 M Linschoten, S Peters, M van Smeden, LS Jewbali, J Schaap, ... European Heart Journal: Acute Cardiovascular Care 9 (8), 817-823, 2020 | 153 | 2020 |
| Chemotherapy-related cardiac dysfunction: a systematic review of genetic variants modulating individual risk M Linschoten, AJ Teske, MJ Cramer, E van der Wall, FW Asselbergs Circulation: Genomic and Precision Medicine 11 (1), e001753, 2018 | 84 | 2018 |
| Truncating titin (TTN) variants in chemotherapy-induced cardiomyopathy M Linschoten, AJ Teske, AF Baas, A Vink, D Dooijes, HF Baars, ... Journal of cardiac failure 23 (6), 476-479, 2017 | 75 | 2017 |
| A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle‐specific genes M Harakalova, G Kummeling, A Sammani, M Linschoten, AF Baas, ... European journal of heart failure 17 (5), 484-493, 2015 | 63 | 2015 |
| CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic M Linschoten, FW Asselbergs European Heart Journal 41 (19), 1795-1796, 2020 | 61 | 2020 |
| Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis A Lopez-Sainz, F Dominguez, LR Lopes, JP Ochoa, R Barriales-Villa, ... Journal of the American College of Cardiology 76 (2), 186-197, 2020 | 59 | 2020 |
| Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study M Henkens, AG Raafs, JAJ Verdonschot, M Linschoten, M Van Smeden, ... BMC geriatrics 22 (1), 184, 2022 | 58 | 2022 |
| Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with … M Linschoten, JAM Kamphuis, A Van Rhenen, LP Bosman, MJ Cramer, ... The Lancet Haematology 7 (4), e295-e308, 2020 | 48 | 2020 |
| Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease–a cohort study across eighteen countries CAPACITY-COVID Collaborative Consortium and LEOSS Study Group, ... MedRxiv, 2021.03. 11.21253106, 2021 | 45 | 2021 |
| Cardio-oncology: an overview on outpatient management and future developments AJ Teske, M Linschoten, JAM Kamphuis, WR Naaktgeboren, T Leiner, ... Netherlands Heart Journal 26, 521-532, 2018 | 43 | 2018 |
| Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis VMT de Jong, RZ Rousset, NE Antonio-Villa, AG Buenen, B Van Calster, ... Bmj 378, 2022 | 35 | 2022 |
| The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19 E McFarlane, M Linschoten, FW Asselbergs, PS Lacy, D Jedrzejewski, ... Hypertension Research 45 (5), 834-845, 2022 | 30 | 2022 |
| Risk, clinical course, and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study WM Sluis, M Linschoten, JE Buijs, JM Biesbroek, HM den Hertog, ... Stroke 52 (12), 3978-3986, 2021 | 29 | 2021 |
| UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking A Sammani, M Jansen, M Linschoten, A Bagheri, N de Jonge, H Kirkels, ... Netherlands Heart Journal 27, 426-434, 2019 | 29 | 2019 |
| Early-and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy JAM Kamphuis, M Linschoten, MJ Cramer, PA Doevendans, ... Cardio-oncology 6 (1), 23, 2020 | 25 | 2020 |
| Long-term cardiovascular health in adult cancer survivors WR Naaktgeboren, M Linschoten, A de Graeff, A v Rhenen, MJ Cramer, ... Maturitas 105, 37-45, 2017 | 19 | 2017 |
| Sex-and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients JA Offerhaus, LPT Joosten, M van Smeden, M Linschoten, H Bleijendaal, ... IJC Heart & Vasculature 39, 100970, 2022 | 15 | 2022 |
| Cancer therapy-related cardiac dysfunction of nonanthracycline chemotherapeutics: what is the evidence? JAM Kamphuis, M Linschoten, MJ Cramer, EH Gort, A van Rhenen, ... Cardio Oncology 1 (2), 280-290, 2019 | 14 | 2019 |
| Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning RR Van de Leur, H Bleijendaal, K Taha, T Mast, J Gho, M Linschoten, ... Netherlands Heart Journal 30 (6), 312-318, 2022 | 9 | 2022 |
